Probi has signed an agreement with the Swedish biotech company, Probac, to acquire a license for two probiotic strains for use in food applications, primarily dairy products.
The license covers the global market, excluding the Nordic countries.
Through the agreement, Probi strengthens its offer in functional food with specific strains for dairy products.
The strains licensed from Probac are based on probiotic research that shows positive effects on the gastrointestinal tract and the immune system.
The strains are currently used in the Verum range of dairy products, including yogurt and soured milk, produced by the Norrmejerier dairy company, which owns the rights for the Nordic market.
The new strains will complement Probi’s existing offer of clinically documented probiotics within the gastro, immune and iron absorption areas.
Probi’s strains are used in both consumer healthcare and functional food products, including chilled beverages such as ProViva and GoodBelly.
The agreement also includes the IP rights for two thermostable strains, which will enable Probi to extend its offer into new applications in new and growing market segments for probiotics.
